Literature DB >> 8355455

Role of hyperglycemia and insulin resistance in determining sodium retention in non-insulin-dependent diabetes.

R Nosadini1, M Sambataro, K Thomaseth, G Pacini, M R Cipollina, E Brocco, A Solini, A Carraro, M Velussi, F Frigato.   

Abstract

Sodium retention has been advocated to give rise to hypertension in humans. Increases in blood glucose and insulin concentrations ensue in the stimulation of sodium reabsorption by the kidney. Although the combined occurrence of hyperglycemia and hyperinsulinemia, frequently secondary to insulin resistance with regard to carbohydrate metabolism, is a hallmark of non-insulin dependent diabetes (NIDDM), the role of these abnormalities in determining an impaired natriuresis in NIDDM is not yet fully understood. We studied sodium homeostasis in 14 control subjects and 59 NIDDM normotensive, normoalbuminuric patients who were divided into two groups with markedly impaired (Group 2 NIDDM: 30) and less severely impaired (Group 1 NIDDM: 29) insulin sensitivity during euglycemic-hyperinsulinemic (80 to 90 microU/ml plasma insulin) clamp. A hyperglycemic (9 mmol/liter plasma glucose)--nearly euinsulinemic (20 to 40 microU/ml plasma insulin) clamp was also performed in the same 14 controls and in two cohorts of 22 Group 2 and 17 Group 1 NIDDM patients. The two groups of patients had similar overnight fasting glucose levels (Group 1 NIDDM vs. Group 2 NIDDM: 176 +/- 13 vs. 185 +/- 15 mg/dl, mean +/- SE). Conversely, overnight fasting plasma insulin was significantly higher in Group 2 NIDDM than in Group 1 NIDDM patients (Group 1 NIDDM vs. Group 2 NIDDM: 12 +/- 3 vs. 18 +/- 3 microU/ml, P < 0.05). Both NIDDM Groups had higher plasma glucose and insulin than controls (75 +/- 4 mg/dl and 6 +/- 3 microU/ml). Blood pressure levels and albumin excretion rates were slightly but significantly higher in Group 2 NIDDM, but not in Group 1 NIDDM patients, than in controls.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355455     DOI: 10.1038/ki.1993.224

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

Review 1.  Treatment of Hypertension in Patients with Diabetes Mellitus: a Contemporary Approach.

Authors:  Ben Alencherry; Luke J Laffin
Journal:  Curr Cardiol Rep       Date:  2021-01-23       Impact factor: 2.931

Review 2.  Cardiovascular risk in children and adolescents with type 2 diabetes mellitus.

Authors:  Christopher Prendergast; Samuel S Gidding
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

Review 3.  The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus.

Authors:  Rabea Asleh; Mohammad Sheikh-Ahmad; Alexandros Briasoulis; Sudhir S Kushwaha
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

4.  ADDRESSING HYPERTENSION IN THE PATIENT WITH TYPE 2 DIABETES MELLITUS: PATHOGENESIS, GOALS, AND THERAPEUTIC APPROACH.

Authors:  Ali A Rizvi
Journal:  Eur Med J Diabetes       Date:  2017-10

Review 5.  Hypertension in diabetes and the risk of cardiovascular disease.

Authors:  Nirmal Sunkara; Chowdhury H Ahsan
Journal:  Cardiovasc Endocrinol       Date:  2017-02-15

Review 6.  Update on blood pressure goals in diabetes mellitus.

Authors:  Luke J Laffin; George L Bakris
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

7.  Enhanced phosphorylation of Na(+)-Cl- co-transporter in experimental metabolic syndrome: role of insulin.

Authors:  Radko Komers; Shaunessy Rogers; Terry T Oyama; Bei Xu; Chao-Ling Yang; James McCormick; David H Ellison
Journal:  Clin Sci (Lond)       Date:  2012-12       Impact factor: 6.124

Review 8.  Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.

Authors:  Andrew S Bomback; Philip J Klemmer
Journal:  Am J Nephrol       Date:  2009-03-20       Impact factor: 3.754

9.  Metabolic syndrome and renal sodium handling in three ethnic groups living in England.

Authors:  A Barbato; F P Cappuccio; E J Folkerd; P Strazzullo; B Sampson; D G Cook; K G M M Alberti
Journal:  Diabetologia       Date:  2003-11-15       Impact factor: 10.122

Review 10.  SGLT2 Inhibitors and Mechanisms of Hypertension.

Authors:  Alexandros Briasoulis; Omar Al Dhaybi; George L Bakris
Journal:  Curr Cardiol Rep       Date:  2018-01-19       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.